FDA Inspection 1179406 — ONESOURCE SPECIALTY PHARMA LIMITED

ONESOURCE SPECIALTY PHARMA LIMITED — FEI 3017501030

The FDA completed an inspection of ONESOURCE SPECIALTY PHARMA LIMITED on September 1, 2022 in Bengaluru. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 1, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Compliance: Devices
Location
Bengaluru (India)

Citations

IDCFRDescription
230221 CFR 820.20(e)Quality System Procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
369621 CFR 820.100(b)Documentation